2801 - 2825 of 7939 Results
Title
Year
- Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target2021RESTRICTEDTitle: Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential targetJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 88Issue #: 1Start Page: 64End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/bcp.14964Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.14964Citation Count: 18
-
OPENTitle: A Survey of People With Parkinson’s and Their Carers: The Management of Pain in Parkinson’sJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 35Issue #: 4Start Page: 613End Page: 621Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/08919887211023592Best OA location URL: https://doi.org/10.1177/08919887211023592Citation Count: 8
- APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains2021OPENTitle: APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brainsJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-021-00803-9Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/s13041-021-00803-9Citation Count: 18
- Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting2021OPENTitle: Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meetingJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00868-7Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-021-00868-7Citation Count: 1
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression2021OPENTitle: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2444End Page: 2446Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28715Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530949Citation Count: 31
-
RESTRICTEDTitle: Telemedicine and Deep brain stimulation - Current practices and recommendationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 199End Page: 205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.001Citation Count: 22
-
RESTRICTEDTitle: Asymmetry at Disease Onset Is Not a Predictor of Parkinson’s Disease ProgressionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1689End Page: 1694Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202525Citation Count: 6
- Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology2021OPENTitle: Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based NosologyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 14Start Page: 7292End Page: 7292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22147292Best OA location URL: https://www.mdpi.com/1422-0067/22/14/7292/pdf?version=1626760200Citation Count: 7
- Parkinson’s Disease Motor Symptom Progression Slowed with Multisensory Dance Learning over 3-Years: A Preliminary Longitudinal Investigation2021OPENTitle: Parkinson’s Disease Motor Symptom Progression Slowed with Multisensory Dance Learning over 3-Years: A Preliminary Longitudinal InvestigationJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 7Start Page: 895End Page: 895Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11070895Best OA location URL: https://www.mdpi.com/2076-3425/11/7/895/pdf?version=1625647210Citation Count: 19
- Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling2021OPENTitle: Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and FallingJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1957End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212636Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212636?id=journal-of-parkinsons-disease%2Fjpd212636Citation Count: 11
-
OPENTitle: Prescribing Aducanumab in the Face of Meager Efficacy and Real RisksJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 11Start Page: 545End Page: 547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452Best OA location URL: https://n.neurology.org/content/neurology/97/11/545.full.pdfCitation Count: 28
- Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesis2021RESTRICTEDTitle: Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesisJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.816Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262606Citation Count: 1
- TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease2021OPENTitle: TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00200-yBest OA location URL: https://www.nature.com/articles/s41531-021-00200-y.pdfCitation Count: 4
- Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study2021OPENTitle: Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization studyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-93105-yBest OA location URL: https://www.nature.com/articles/s41598-021-93105-y.pdfCitation Count: 22
-
OPENTitle: Copy Number Variation in Parkinson's Disease: An Update from Sub‐Saharan AfricaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2442End Page: 2444Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28710Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530875Citation Count: 3
- Plant immune system activation is necessary for efficient interaction with auxin secreting beneficial bacteria2021RESTRICTEDTitle: Plant immune system activation is necessary for efficient interaction with auxin secreting beneficial bacteriaJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17632/8zyrz7ccbh.1Citation Count: 0
- Diagnostic accuracy of narrow‐band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: A systematic review and meta‐analysis2021RESTRICTEDTitle: Diagnostic accuracy of narrow‐band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: A systematic review and meta‐analysisJournal Name: Journal of Gastroenterology and HepatologyPublisher: WileyVol: 36Issue #: 10Start Page: 2659End Page: 2671Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/jgh.15577Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgh.15577Citation Count: 15
-
RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 0
-
OPENTitle: They Look but Do Not See—Gaze‐Evoked Eyelid SpasmJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1123End Page: 1125Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13279Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13279Citation Count: 0
- Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist2021RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Citation Count: 14
- Arousal characteristics in patients with Parkinson’s disease and isolated rapid eye movement sleep behavior disorder2021OPENTitle: Arousal characteristics in patients with Parkinson’s disease and isolated rapid eye movement sleep behavior disorderJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 44Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsab167Best OA location URL: https://academic.oup.com/sleep/article-pdf/44/12/zsab167/41608831/zsab167.pdfCitation Count: 5
- Elevated Mood States in Patients With Parkinson’s Disease Treated With Deep Brain Stimulation: Diagnosis and Management Strategies2021RESTRICTEDTitle: Elevated Mood States in Patients With Parkinson’s Disease Treated With Deep Brain Stimulation: Diagnosis and Management StrategiesJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 33Issue #: 4Start Page: 314End Page: 320Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.20080205Citation Count: 8
-
OPENTitle: Lifestyle Factors and Parkinson’s Disease Risk in a Rural New England Case-Control StudyJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2021Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/5541760Best OA location URL: https://downloads.hindawi.com/journals/pd/2021/5541760.pdfCitation Count: 3
-
OPENTitle: SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00468-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00468-xCitation Count: 12
-
RESTRICTEDTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 31